Literature DB >> 26277745

Recent advancement of gelatin nanoparticles in drug and vaccine delivery.

Nityananda Sahoo1, Ranjan Ku Sahoo1, Nikhil Biswas1, Arijit Guha1, Ketousetuo Kuotsu2.   

Abstract

Novel drug delivery system using nanoscale materials with a broad spectrum of applications provides a new therapeutic foundation for technological integration and innovation. Nanoparticles are suitable drug carrier for various routes of administration as well as rapid recognition by the immune system. Gelatin, the biological macromolecule is a versatile drug/vaccine delivery carrier in pharmaceutical field due to its biodegradable, biocompatible, non-antigenicity and low cost with easy availability. The surface of gelatin nanoparticles can be modified with site-specific ligands, cationized with amine derivatives or, coated with polyethyl glycols to achieve targeted and sustained release drug delivery. Compared to other colloidal carriers, gelatin nanoparticles are better stable in biological fluids to provide the desired controlled and sustained release of entrapped drug molecules. The current review highlights the different formulation aspects of gelatin nanoparticles which affect the particle characteristics like zeta potential, polydispersity index, entrapment efficacy and drug release properties. It has also given emphasis on the major applications of gelatin nanoparticles in drug and vaccine delivery, gene delivery to target tissues and nutraceutical delivery for improving the poor bioavailabity of bioactive phytonutrients.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Entrapment efficacy; Gelatin nanoparticles; Vaccine delivery

Mesh:

Substances:

Year:  2015        PMID: 26277745     DOI: 10.1016/j.ijbiomac.2015.08.006

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  29 in total

1.  Diclofenac Loaded Lipid Nanovesicles Prepared by Double Solvent Displacement for Skin Drug Delivery.

Authors:  M Sala; F Locher; M Bonvallet; G Agusti; A Elaissari; H Fessi
Journal:  Pharm Res       Date:  2017-06-19       Impact factor: 4.200

Review 2.  miRNAs in gastrointestinal diseases: can we effectively deliver RNA-based therapeutics orally?

Authors:  A K M Nawshad Hossian; Gerardo G Mackenzie; George Mattheolabakis
Journal:  Nanomedicine (Lond)       Date:  2019-11-18       Impact factor: 5.307

3.  Investigating preparation and characterisation of diphtheria toxoid-loaded on sodium alginate nanoparticles.

Authors:  Samira Aghamiri; Mojtaba Noofeli; Parvaneh Saffarian; Zahra Salehi Najafabadi; Hamid Reza Goudarzi
Journal:  IET Nanobiotechnol       Date:  2022-05-24       Impact factor: 2.050

Review 4.  Recent trends in protein and peptide-based biomaterials for advanced drug delivery.

Authors:  Anastasia Varanko; Soumen Saha; Ashutosh Chilkoti
Journal:  Adv Drug Deliv Rev       Date:  2020-08-29       Impact factor: 15.470

Review 5.  Nanotechnology for angiogenesis: opportunities and challenges.

Authors:  Saeid Kargozar; Francesco Baino; Sepideh Hamzehlou; Michael R Hamblin; Masoud Mozafari
Journal:  Chem Soc Rev       Date:  2020-06-15       Impact factor: 54.564

6.  Poly(glycerol sebacate) nanoparticles for ocular delivery of sunitinib: physicochemical, cytotoxic and allergic studies.

Authors:  Sana Pirmardvand Chegini; Jaleh Varshosaz; Hamid Mirmohammad Sadeghi; Alireza Dehghani; Mohsen Minayian
Journal:  IET Nanobiotechnol       Date:  2019-12       Impact factor: 1.847

7.  Controllable synthesis and characterisation of palladium (II) anticancer complex-loaded colloidal gelatin nanoparticles as a novel sustained-release delivery system in cancer therapy.

Authors:  Neda Alasvand; Maryam Saeidifar; Ali Akbar Saboury; Masoud Mozafari
Journal:  IET Nanobiotechnol       Date:  2017-08       Impact factor: 1.847

Review 8.  Preparation and Application of Cell Membrane-Camouflaged Nanoparticles for Cancer Therapy.

Authors:  Yihui Zhai; Jinghan Su; Wei Ran; Pengcheng Zhang; Qi Yin; Zhiwen Zhang; Haijun Yu; Yaping Li
Journal:  Theranostics       Date:  2017-06-25       Impact factor: 11.556

9.  Curcumin-carrying nanoparticles prevent ischemia-reperfusion injury in human renal cells.

Authors:  Yong Xu; Ning Hu; Wei Jiang; Hong-Fang Yuan; Dong-Hui Zheng
Journal:  Oncotarget       Date:  2016-12-27

Review 10.  Bench-to-Bedside in Vascular Medicine: Optimizing the Translational Pipeline for Patients With Peripheral Artery Disease.

Authors:  Tom Alsaigh; Belinda A Di Bartolo; Jocelyne Mulangala; Gemma A Figtree; Nicholas J Leeper
Journal:  Circ Res       Date:  2021-06-10       Impact factor: 23.213

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.